← Back to Search

Neurostimulation

Translingual neurostimulation for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Research Sponsored by HealthTech Connex Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 6
Awards & highlights

Study Summary

This trial will test whether a new treatment, combining transcranial electrical stimulation with cognitive processing therapy, is feasible for people with PTSD.

Eligible Conditions
  • Post Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinician-rated symptom severity as measured by CAPS
Ease of protocol administration
Participant rated symptom severity as measured by the PCL-5
+3 more
Secondary outcome measures
Brief Inventory of Psychosocial Functioning (B-IPF)
Electroencephalography (EEG)
Generalized Anxiety Disorder 7-item (GAD-7)
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TLNSExperimental Treatment1 Intervention
Translingual neurostimulation will be paired with breathing and awareness training prior to CPT sessions
Group II: ControlActive Control1 Intervention
No TLNS
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Translingual neurostimulation
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Centre for Neurology StudiesUNKNOWN
HealthTech Connex Inc.Lead Sponsor
4 Previous Clinical Trials
168 Total Patients Enrolled
~3 spots leftby May 2025